Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
43,666,020
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
29,702,499
-
Shares change
-
+3,614,619
-
Total reported value, excl. options
-
$768,778,734
-
Value change
-
+$87,583,327
-
Number of buys
-
46
-
Number of sells
-
45
-
Price
-
$25.88
Institutional Holders of Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value (DNTH) as of Q2 2024
As of 30 Jun 2024 Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value (DNTH) had 103 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 29,702,499 shares of stock of the company.
Largest 10 holders included FMR LLC, Bain Capital Life Sciences Investors, LLC, Avidity Partners Management LP, Fairmount Funds Management LLC, RA CAPITAL MANAGEMENT, L.P., VR Adviser, LLC, Octagon Capital Advisors LP, BlackRock Inc., VANGUARD GROUP INC, and 5AM Venture Management, LLC.
This table shows 103 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.